It is created in the human brain, liver, and kidneys
In contrast, the buildup of lipid ROS and the consequent onset of ferroptosis can be hindered through intervention with iron-chelating agents (e.g., deferoxamine) and lipophilic antioxidants (e.g., ferrostatin-1 and liproxstatin-1) [77]
The main patient-facing takeaway is the potential for simpler oral use, while effectiveness and tolerability still need to be judged in context
It would help if you had a lot of extra protection
Synergistic Efficacy of CPI 613 Combined with Enz in PCa Treatment CPI 613, a novel PDHA1 inhibitor, has demonstrated antitumor activity by disrupting mitochondrial metabolism through phosphorylation and inactivation of PDHA1, which plays a key role in PCa cell survival, and exhibits low toxicity to normal prostate epithelial cells (RWPE1) while effectively killing PCa cells (Supplementary Fig